A placebo—verum difference in antidepressant response of at least three points on the Hamilton Depression Rating Scale has been proposed as the threshold for clinical significance in antidepressant trials. Given the considerable clinical and regulatory consequences of such a definition of clinical relevance it deserves a critical discussion. Eight arguments are presented indicating that using this definition as a criterion for assessing the clinical utility of antidepressants in daily practice would risk erroneously discarding treatments with a clear benefit for patients.
Blier P., Keller MB, Pollack MH, Thase ME, Zajecka JM, Dunner DL ( 2007) Preventing recurrent depression: long-term treatment for major depressive disorder. Journal of Clinical Psychiatry68: e06.
2.
Demyttenaere K., Adelin A., Patrick M., Walthère D., de Katrien B., Michèle S. ( 2008) Six-month compliance with antidepressant medication in the treatment of major depressive disorder. International Clinical Psychopharmacology23: 36-42.
3.
Demyttenaere K., Van Ganse E., Gregoire J., Gaens E., Mesters P. ( 1998) Compliance in depressed patients treated with fluoxetine or amitriptyline. Belgian Compliance Study Group. International Clinical Psychopharmacology13: 11-17.
4.
Geddes JR, Carney SM, Davies C., et al. (2003) Relapse prevention with antidepressant drug treatment in depressive disorders: a systematic review. Lancet361: 653-661.
5.
Geddes J., Freemantle N., Mason J., Eccles M., Boynton J. ( 2006) Selective serotonin reuptake inhibitors (SSRIs) versus other antidepressants for depression. Cochrane Database of Systematic Reviews3: CD001851.
6.
Gibbons RD, Brown CH, Hur K., et al. (2007) Early evidence on the effects of regulators’ suicidality warnings on SSRI prescriptions and suicide in children and adolescents . American Journal of Psychiatry164: 1356-1363.
7.
Hamilton M. ( 1960) A rating scale for depression. Journal of Neurology, Neurosurgery, and Psychiatry23: 56-62.
8.
Hegerl U., Hautzinger M., Mergl R., et al. (2009) Effects of pharmacoand psychotherapy in depressed primary care patients. A randomised, controlled trial including a patient choice arm. International Journal of Neuropsychopharmacology (doi: 10.1017/ S1461145709000224).
9.
Henkel V., Seemüller F., Obermeier M., et al. (2008) Does early improvement triggered by antidepressants predict response/remission? Analysis of data from a naturalistic study on a large sample of inpatients with major depression. Journal of Affective Disorders115: 439-449.
10.
Hotopf M., Hardy R., Lewis G. ( 1997) Discontinuation rates of SSRIs and tricyclic antidepressants: a meta-analysis and investigation of heterogeneity. British Journal of Psychiatry170: 120-127.
11.
Katz LY, Kozyrskyj AL, Prior HJ, Enns MW, Cox BJ, Sareen J. ( 2008) Effect of regulatory warnings on antidepressant prescription rates, use of health services and outcomes among children, adolescents and young adults. Canadian Medical Association Journal178: 1005-1011.
12.
Kirsch I., Deacon BJ, Hudeo-Medina TB, Scoboria A., Moore TJ, Johnson BT ( 2008) Initial severity and antidepressant benefits: A meta-analysis of data submitted to the Food and Drug Administration. PLoS Medicine5: e45.
13.
Kornstein SG ( 2008) Maintenance therapy to prevent recurrence of depression: summary and implications of the PREVENT study. Expert Review of Neurotherapeutics8: 737-742.
14.
NICE (National Institute for Clinical Excellence) ( 2004) Depression: Management of Depression in Primary and Secondary Care. Clinical Practice Guideline No. 23. London, UK: National Institute for Clinical Excellence.
15.
Möler H.-J (2008) Isn’t the efficacy of antidepressants clinically relevant? A critical comment on the results of the metaanalysis by Kirsch et al. 2008. European Archives of Psychiatry and Clinical Neuroscience258: 451-455.
16.
Nutt DJ, Sharpe M. ( 2008) Uncritical positive regard? Issues in the efficacy and safety of psychotherapy. Journal of Psychopharmacology22: 3-6.
17.
Papakostas GI, Perlis RH, Scalia MJ, Petersen TJ, Fava M. ( 2006) A meta-analysis of early sustained response rates between antidepressants and placebo for the treatment of major depressive disorder . Journal of Clinical Psychopharmacology26: 56-60.
18.
Peveler R., George C., Kinmonth A-L., Campbell M., Thompson C. ( 1999) Effect of antidepressant drug counselling and information leaflets on adherence to drug treatment in primary care: randomised controlled trial. British Medical Journal319: 612-615.
19.
Reynolds CF III, Dew MA, Pollock BG, et al. (2006) Maintenance treatment of major depression in old age. New England Journal of Medicine354: 1130-1138.
20.
Rihmer Z., Gonda X. ( 2008) Is drug-placebo difference in short-term antidepressant drug trials on unipolar major depression much greater than previously believed ? Journal of Affective Disorders108: 195-198.
21.
Sneed JR, Rutherford BR, Rindskopf D., Lane DT, Sackeim HA, Roose SP ( 2008) Design makes a difference: a meta-analysis of antidepressant response rates in placebo-controlled versus comparator trials in late-life depression. American Journal of Geriatric Psychiatry16: 65-73.
22.
Stassen HH, Angst J., Hell D., Scharfetter C., Szegedi A. ( 2007) Is there a common resilience mechanism underlying antidepressant drug response? Evidence from 2848 patients. Journal of Clinical Psychiatry68: 1195-1205.
23.
Szegedi A., Müler MJ, Anghelescu I., Klawe C., Kohnen R., Benkert O. ( 2003) Early improvement under mirtazapine and paroxetine predicts later stable response and remission with high sensitivity in patients with major depression. Journal of Clinical Psychiatry64: 413-420.
24.
Tadić A., Helmreich I., Mergl R., et al. (2009) Early improvement is a predictor of treatment outcome in patients with mild major, minor or subsyndromal depression. Journal of Affective Disorders (doi: 10.1016/j.jad.2009.04.014).
25.
Taylor MJ, Freemantle N., Geddes JR, Bhagwagar Z. ( 2006) Early onset of selective serotonin reuptake inhibitor antidepressant action: systematic review and meta-analysis. Archives of General Psychiatry63: 1217-1223.
26.
Thompson C., Peveler RC, Stephenson D., McKendrick J. ( 2000) Compliance with antidepressant medication in the treatment of major depressive disorder in primary care: A randomized comparison of fluoxetine and a tricyclic antidepressant. American Journal of Psychiatry157: 338-343.
27.
van Calker D., Zobel I., Dykierek P., et al. (2009) Time course of response to antidepressants: Predictive value of early improvement and effect of additional psychotherapy. Journal of Affective Disorders114: 243-253.
28.
Walsh BT, Seidman SN, Sysko R., Gould M. ( 2002) Placebo response in studies of major depression: variable, substantial, and growing. Journal of the American Medical Association287: 1840-1847.
